Skylight Health Group Inc., a healthcare services and technology company in the United States, Canada, the United Kingdom, and Colombia. More Details
High growth potential with adequate balance sheet.
Share Price & News
How has Skylight Health Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: SHG is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 11% a week.
Volatility Over Time: SHG's weekly volatility (11%) has been stable over the past year.
7 Day Return
CA Healthcare Services
1 Year Return
CA Healthcare Services
Return vs Industry: SHG exceeded the Canadian Healthcare Services industry which returned 114% over the past year.
Return vs Market: SHG exceeded the Canadian Market which returned 39.2% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Skylight Health Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
6 months ago | Simply Wall StCB2 Insights' (CSE:CBII) Wonderful 437% Share Price Increase Shows How Capitalism Can Build Wealth
11 months ago | Simply Wall StCB2 Insights (CSE:CBII) Is Making Moderate Use Of Debt
1 year ago | Simply Wall StWhat Kind Of Shareholder Appears On The CB2 Insights Inc.'s (CSE:CBII) Shareholder Register?
Is Skylight Health Group undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: SHG (CA$1.59) is trading below our estimate of fair value (CA$1.92)
Significantly Below Fair Value: SHG is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: SHG is unprofitable, so we can't compare its PE Ratio to the North American Healthcare Services industry average.
PE vs Market: SHG is unprofitable, so we can't compare its PE Ratio to the Canadian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate SHG's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: SHG is overvalued based on its PB Ratio (10.1x) compared to the CA Healthcare Services industry average (7.7x).
How is Skylight Health Group forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SHG is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.5%).
Earnings vs Market: SHG is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: SHG's is expected to become profitable in the next 3 years.
Revenue vs Market: SHG's revenue (28.1% per year) is forecast to grow faster than the Canadian market (6.3% per year).
High Growth Revenue: SHG's revenue (28.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SHG's Return on Equity is forecast to be high in 3 years time
How has Skylight Health Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SHG is currently unprofitable.
Growing Profit Margin: SHG is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: SHG is unprofitable, and losses have increased over the past 5 years at a rate of 41.3% per year.
Accelerating Growth: Unable to compare SHG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SHG is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (18.1%).
Return on Equity
High ROE: SHG has a negative Return on Equity (-34.31%), as it is currently unprofitable.
How is Skylight Health Group's financial position?
Financial Position Analysis
Short Term Liabilities: SHG's short term assets (CA$21.4M) exceed its short term liabilities (CA$2.7M).
Long Term Liabilities: SHG's short term assets (CA$21.4M) exceed its long term liabilities (CA$1.1M).
Debt to Equity History and Analysis
Debt Level: SHG's debt to equity ratio (2.8%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if SHG's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SHG has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if SHG has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is Skylight Health Group current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate SHG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SHG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SHG's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SHG's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of SHG's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Pradyum Sekar, also known as Prad, is the Co-Founder of Skylight Health Group Inc. (formerly known as CB2 Insights Inc.) and has been its Chief Executive Officer, Secretary and Director since February ...
CEO Compensation Analysis
Compensation vs Market: Prad's total compensation ($USD185.07K) is below average for companies of similar size in the Canadian market ($USD471.71K).
Compensation vs Earnings: Prad's compensation has increased whilst the company is unprofitable.
Experienced Management: SHG's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Experienced Board: SHG's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: SHG insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 112.8%.
Skylight Health Group Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Skylight Health Group Inc.
- Ticker: SHG
- Exchange: TSXV
- Founded: 2014
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: CA$287.299m
- Shares outstanding: 180.69m
- Website: https://www.skylighthealthgroup.com
Number of Employees
- Skylight Health Group Inc.
- Unit 402
- 5520 Explorer Drive
- L4W 5L1
Skylight Health Group Inc., a healthcare services and technology company in the United States, Canada, the United Kingdom, and Colombia. The Company operates a US multi-state primary care health network th...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/15 23:15|
|End of Day Share Price||2021/05/14 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.